Efficacy and desensitization profile of selexipag (Actelion Pharmaceuticals Ltd): This video shows the cellular shape change monitored in real time using the 3D Cell Explorer. These data suggest that IP receptor agonists effectively attenuated pro-contractile signaling pathways and actomyosin contraction in pulmonary arterial smooth muscle cells.